MiLOC Group Limited - Result of AGM and Change of Company Name Update
RNS Number : 2192F
MiLOC Group Limited
03 November 2022
 

3 November 2022

 

 

MiLOC GROUP LIMITED

("MiLOC" or "the Company")

(To be renamed CRUSHMETRIC GROUP LIMITED)

 

Result of Annual General Meeting and Change of Company Name Update

 

 

MiLOC Group Limited, the AQSE Growth Market quoted pharmaceutical and healthcare group and design/production company, is pleased to announce that at the Company's Annual General Meeting held yesterday, all resolutions were duly passed.

 

One of the resolutions was to change the name of the Company from that of MiLOC Group Limited to CRUSHMETRIC Group Limited, to better reflect the change in the Company's new strategy. Shareholders should take note of the new name and that it may take some time for all the news and data platforms used by investors to make this change to their systems. The Company is growing the business of its newly acquired wholly-owned subsidiary, CRUSHMETRIC Limited.

 

The Company is in the process of creating a new website, under a new domain name. A further announcement will be made in due course when the website is ready to be launched.

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

 

For further information, please contact:-

 

MiLOC

ONG Ban Poh Michael - Chief Executive Officer

Lilian Lo - Acting Chief Financial Officer

 

 

 

 

Tel: +852 2110 4221

 

AQSE Growth Market Corporate Adviser

PETERHOUSE CAPITAL LIMITED

Guy Miller

Mark Anwyl

 

Tel: +44 (0) 20 7469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXGCBDBUXGDGDX ]]>